CS1-PEPTIDE

Patent europeic · EP3384919 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3384919
Numer da la dumonda
EP18162674
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-06-2009
Publitgà
10-10-2018
Concedì
01-04-2026
La protecziun finescha il pli tard
31-05-2029
Proxima taxa annuala scadenta
30-06-2026
Classas IPC
A61K 38/00 (2006.01)
C07K 14/705 (2006.01)
C07K 14/47 (2006.01)
A61P 35/02 (2006.01)
A61P 43/00 (2006.01)
A61K 40/11 (2025.01)
A61K 40/42 (2025.01)
A61P 35/00 (2006.01)
A61P 39/00 (2006.01)
Prioritad
US 58180 P 02.06.2008
Derivà da
EP09759182
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-04-2026

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 17.04.2026

  2. 01-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.04.2026

Partidas

Possessur

Dana-Farber Cancer Institute, Inc.

450 Brookline Avenue, Boston, MA 02215, US

Represchentant

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventur

BAE, Jooeun

West Roxbury, MA 02132, US

ANDERSON, Kenneth

Wellesley, MA 02482, US

MUNSHI, Nikhil

Needham, MA 02494, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.